Open AccessNanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic
Author(s) -
Wang Ziqi,
Cui Kai,
Costabel Ulrich,
Zhang Xiaoju
Publication year - 2022
Publication title -
exploration
Language(s) - English
Resource type - Journals
eISSN - 2766-2098
pISSN - 2766-8509
DOI - 10.1002/exp.20210082
Subject(s) - pandemic , covid-19 , coronavirus , vaccination , nanotechnology , virology , disease , medicine , infectious disease (medical specialty) , materials science , outbreak , pathology
Abstract Coronavirus disease 2019 (COVID‐19) continually poses a significant threat to the human race, and prophylactic vaccination is the most potent approach to end this pandemic. Nanotechnology is widely adopted during COVID‐19 vaccine development, and the engineering of nanostructured materials such as nanoparticles has opened new possibilities in innovative vaccine development by improving the design and accelerating the development process. This review aims to comprehensively understand the current situation and prospects of nanotechnology‐enabled vaccine development against the COVID‐19 pandemic, with an emphasis on the interplay between nanotechnology and the host immune system.